HealthEquity Inc (HQY)

Gross profit margin

		Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Oct 31, 2020	Jul 31, 2020	Apr 30, 2020	Jan 31, 2020	Oct 31, 2019	Jul 31, 2019	Apr 30, 2019
Gross profit (ttm)	US$ in thousands	622,637	594,090	562,226	528,373	491,076	461,602	437,604	431,763	423,706	419,325	420,563	410,376	415,334	428,097	419,574	376,230	325,909	256,673	206,455	194,590
Revenue (ttm)	US$ in thousands	958,410	916,132	884,134	848,438	815,511	788,427	748,466	735,565	717,815	706,638	714,959	700,254	700,489	719,841	694,134	614,980	525,114	399,691	323,044	305,671
Gross profit margin		64.97%	64.85%	63.59%	62.28%	60.22%	58.55%	58.47%	58.70%	59.03%	59.34%	58.82%	58.60%	59.29%	59.47%	60.45%	61.18%	62.06%	64.22%	63.91%	63.66%

January 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $622,637K ÷ $958,410K
= 64.97%

HealthEquity Inc's gross profit margin has shown a generally positive trend over the past few years, indicating effective cost management and revenue generation. The margin has steadily increased from 58.47% in April 2022 to 64.97% in January 2024. This suggests that the company has been able to effectively control its production costs and increase its pricing power. The consistent improvement in the gross profit margin reflects the company's ability to maintain a healthy balance between revenue and cost of goods sold. Overall, the increasing trend in HealthEquity Inc's gross profit margin is a positive indicator of its operational efficiency and profitability.